{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:37:50Z","timestamp":1791027470689,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.jns.2008.09.033","type":"journal-article","created":{"date-parts":[[2008,10,27]],"date-time":"2008-10-27T08:05:10Z","timestamp":1225094710000},"page":"150-154","source":"Crossref","is-referenced-by-count":24,"title":["Terbutaline in myasthenia gravis: A pilot study"],"prefix":"10.1016","volume":"277","author":[{"given":"Betty","family":"Soliven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourosh","family":"Rezania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Gundogdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Harding-Clay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Oger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry G.W.","family":"Arnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jns.2008.09.033_bib1","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2008.09.033_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0192-0561(92)90082-V","article-title":"Sympathetic nervous system modulates macrophage function","volume":"14","author":"Chelmicka-Schorr","year":"1992","journal-title":"Int J Immunopharmacol"},{"issue":"2","key":"10.1016\/j.jns.2008.09.033_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1046\/j.1471-4159.1995.64020883.x","article-title":"Tumor necrosis factor-alpha regulates nicotinic responses in mixed cultures of sympathetic neurons and nonneuronal cells","volume":"64","author":"Soliven","year":"1995","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.jns.2008.09.033_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-5793(86)81235-2","article-title":"A possible involvement of cyclic AMP in the expression of desensitization of the nicotinic acetylcholine receptor. A study with forskolin and its analogs","volume":"199","author":"Albuquerque","year":"1986","journal-title":"FEBS Lett"},{"issue":"Pt 3","key":"10.1016\/j.jns.2008.09.033_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1113\/jphysiol.2001.012752","article-title":"Protein kinase A cascade regulates quantal release dispersion at frog muscle endplate","volume":"538","author":"Bukharaeva","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.jns.2008.09.033_bib6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.1933.27420180001007","article-title":"The effect of ephedrine in the treatment of myasthenia gravis","volume":"100","author":"Edgeworth","year":"1933","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jns.2008.09.033_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000167132.35865.31","article-title":"Congenital endplate acetylcholinesterase deficiency responsive to ephedrine","volume":"65","author":"Bestue-Cardiel","year":"2005","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.jns.2008.09.033_bib8","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/brain\/awl200","article-title":"Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with \u2018limb-girdle myasthenia\u2019","volume":"129","author":"Slater","year":"2006","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jns.2008.09.033_bib9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0028-3908(79)90018-2","article-title":"Ephedrine: a postsynaptic depressant drug at the mammalian neuromuscular junction","volume":"18","author":"Shinnick-Gallagher","year":"1979","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jns.2008.09.033_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90025-I","article-title":"Ephedrine: effects on neuromuscular transmission","volume":"623","author":"Sieb","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2008.09.033_bib11","first-page":"67","article-title":"Nervous system\u2013immune system interactions","volume":"68","author":"Chelmicka-Schorr","year":"1990","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"issue":"4","key":"10.1016\/j.jns.2008.09.033_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0031-6997(24)01510-2","article-title":"Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo","volume":"53","author":"Kohm","year":"2001","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.jns.2008.09.033_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0192-0561(93)90027-V","article-title":"The beta2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG)","volume":"15","author":"Chelmicka-Schorr","year":"1993","journal-title":"Int J Immunopharmacol"},{"issue":"12","key":"10.1016\/j.jns.2008.09.033_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jns.2008.09.033_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1212\/WNL.38.5.818","article-title":"Antibody production by blood lymphocytes in myasthenia gravis: reduction in disease of long duration","volume":"38","author":"Kaufman","year":"1988","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2008.09.033_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/(SICI)1097-4598(199608)19:8<959::AID-MUS4>3.0.CO;2-7","article-title":"Acute effects of intravenous injection of beta-adrenoreceptor- and calcium channel antagonists and agonists in myasthenia gravis","volume":"19","author":"Jonkers","year":"1996","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.jns.2008.09.033_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000117380","article-title":"Fulminant myasthenia gravis soon after initiation of acebutolol therapy","volume":"30","author":"Confavreux","year":"1990","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jns.2008.09.033_bib18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1749-6632.1998.tb11019.x","article-title":"Calcium channel and beta-receptor antagonists and agonists in MG","volume":"841","author":"Matell","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.jns.2008.09.033_bib19","first-page":"214","article-title":"Potentiation of pyridostigmine bromide toxicity in mice by selected adrenergic agents and caffeine","volume":"39","author":"Chaney","year":"1997","journal-title":"Vet Hum Toxicol"},{"issue":"3","key":"10.1016\/j.jns.2008.09.033_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1113\/jphysiol.1970.sp009293","article-title":"Effects of catecholamines on the neuromuscular junction in the rat diaphragm","volume":"211","author":"Kuba","year":"1970","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.jns.2008.09.033_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0896-6273(91)90254-W","article-title":"Cyclic AMP stabilizes the degradation of original junctional acetylcholine receptors in denervated muscle","volume":"6","author":"Shyng","year":"1991","journal-title":"Neuron"},{"issue":"3\u20134","key":"10.1016\/j.jns.2008.09.033_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF00374467","article-title":"Effects of activators and inhibitors of protein kinase A on increases in quantal size at the frog neuromuscular junction","volume":"420","author":"Van der Kloot","year":"1992","journal-title":"Pflugers Arch"},{"issue":"2","key":"10.1016\/j.jns.2008.09.033_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-5728(95)00169-7","article-title":"Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis","volume":"64","author":"Li","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.jns.2008.09.033_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.33549\/physiolres.930000.49.475","article-title":"Cyclic AMP synchronizes evoked quantal release at frog neuromuscular junctions","volume":"49","author":"Bukcharaeva","year":"2000","journal-title":"Physiol Res"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.09.033_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00374515","article-title":"Changes of tension and [Ca2+]i during beta-adrenoceptor activation of single, intact fibres from mouse skeletal muscle","volume":"425","author":"Cairns","year":"1993","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jns.2008.09.033_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-5728(87)90145-7","article-title":"Sympathectomy enhances the severity of experimental autoimmune myasthenia gravis (EAMG)","volume":"16","author":"Agius","year":"1987","journal-title":"J Neuroimmun"},{"issue":"3","key":"10.1016\/j.jns.2008.09.033_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01868456","article-title":"Beta-adrenergic modulation of K+ current in human T lymphocytes","volume":"117","author":"Soliven","year":"1990","journal-title":"J Membr Biol"},{"issue":"5950","key":"10.1016\/j.jns.2008.09.033_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/307465a0","article-title":"Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?","volume":"307","author":"DeCoursey","year":"1984","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jns.2008.09.033_bib29","first-page":"107","article-title":"Functional roles of ion channels in lymphocytes","volume":"2","author":"Cahalan","year":"1990","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.jns.2008.09.033_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-5728(91)90084-K","article-title":"The effect of norepinephrine on endotoxin-mediated macrophage activation","volume":"31","author":"Hu","year":"1991","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10.1016\/j.jns.2008.09.033_bib31","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.162.7.3775","article-title":"Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis","volume":"162","author":"Zhang","year":"1999","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.09.033_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-5728(01)00474-X","article-title":"Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis","volume":"122","author":"Goluszko","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.jns.2008.09.033_bib33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/intimm\/12.10.1381","article-title":"Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis","volume":"12","author":"Wang","year":"2000","journal-title":"Int Immunol"},{"issue":"4","key":"10.1016\/j.jns.2008.09.033_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/jaut.2002.0618","article-title":"Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis","volume":"19","author":"Duan","year":"2002","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.09.033_bib35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-5728(01)00473-8","article-title":"Treatment of experimental autoimmune myasthenia gravis with recombinant human tumor necrosis factor receptor Fc protein","volume":"122","author":"Christadoss","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.jns.2008.09.033_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08916930600622256","article-title":"Cytokines in idiopathic inflammatory myopathies","volume":"39","author":"Salomonsson","year":"2006","journal-title":"Autoimmunity"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.09.033_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(98)00159-3","article-title":"Antibodies against beta1 and beta2 adrenergic receptors in myasthenia gravis","volume":"91","author":"Xu","year":"1998","journal-title":"J Neuroimmunol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08005017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08005017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T07:30:55Z","timestamp":1738481455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08005017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0022510X08005017"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.09.033","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}